Javascript must be enabled to continue!
Degranulation of rat omental mast cells by A1 receptor agonists in vitro
View through CrossRef
The haemodynamic effects of adenosine are thought to result in part from a release of mast cell amines via A3 receptor stimulation. To investigate the nature of the receptors involved in adenosine‐induced mast cell degranulation in the rat isolated omentum we have used adenosine analogues with varying specificities as activators of the A1, A2 and A3 receptors, and antagonists with differing specificities for A1 and A2 receptors. Analogues which act predominantly as A1 (e.g. N6‐cyclopentyladenosine) or as mixed A1/A2 receptor agonists (e.g. adenosine, inosine, 5′‐(Nethylcarboxamido) adenosine) caused mast cell degranulation, whereas a predominantly A3 receptor agonist (IB‐MECA) was inactive. Pre‐treatment of the omentum with the A1/A2 receptor antagonist 8‐phenyltheophylline or with the more specific A1 receptor antagonist 8‐cyclopentyl‐1,3‐dipropylxanthine significantly reduced agonist‐induced degranulation. Pre‐treatment with disodium cromoglycate or with BN52021 also reduced degranulation of mast cells in response to N6‐cyclopentyladenosine. In the rat isolated omental mast cell we conclude that degranulation is an indirect result of A1 receptor stimulation. Platelet‐activating factor release appears to mediate at least part of the degranulation.
Title: Degranulation of rat omental mast cells by A1 receptor agonists in vitro
Description:
The haemodynamic effects of adenosine are thought to result in part from a release of mast cell amines via A3 receptor stimulation.
To investigate the nature of the receptors involved in adenosine‐induced mast cell degranulation in the rat isolated omentum we have used adenosine analogues with varying specificities as activators of the A1, A2 and A3 receptors, and antagonists with differing specificities for A1 and A2 receptors.
Analogues which act predominantly as A1 (e.
g.
N6‐cyclopentyladenosine) or as mixed A1/A2 receptor agonists (e.
g.
adenosine, inosine, 5′‐(Nethylcarboxamido) adenosine) caused mast cell degranulation, whereas a predominantly A3 receptor agonist (IB‐MECA) was inactive.
Pre‐treatment of the omentum with the A1/A2 receptor antagonist 8‐phenyltheophylline or with the more specific A1 receptor antagonist 8‐cyclopentyl‐1,3‐dipropylxanthine significantly reduced agonist‐induced degranulation.
Pre‐treatment with disodium cromoglycate or with BN52021 also reduced degranulation of mast cells in response to N6‐cyclopentyladenosine.
In the rat isolated omental mast cell we conclude that degranulation is an indirect result of A1 receptor stimulation.
Platelet‐activating factor release appears to mediate at least part of the degranulation.
Related Results
Abstract B089: Intratumoral expression analysis of mast cells in high grade serous ovarian cancer
Abstract B089: Intratumoral expression analysis of mast cells in high grade serous ovarian cancer
Abstract
Objective: The goal of this study is to examine intratumoral expression and phenotypic changes in mast cells following neoadjuvant chemotherapy (NACT) expos...
Clemastine Fumarate Attenuates Myocardial Ischemia Reperfusion Injury Through Inhibition of Mast Cell Degranulation
Clemastine Fumarate Attenuates Myocardial Ischemia Reperfusion Injury Through Inhibition of Mast Cell Degranulation
Mast cell (MC) activation is associated with myocardial ischemia reperfusion injury (MIRI). Suppression of MC degranulation might be a target of anti-MIRI. This study aimed to dete...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
1.Effect of chronic haloperidol treatment on D‐2 receptors labelled by (3H)‐spiperone in homogenates of rat corpus striatum. A. L. Gundlach, D. J. de Vries and P. M. Beart2.The eff...
Human skin–derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes
Human skin–derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes
AbstractHuman mast cells in adult tissues have been thought to have limited, if any, proliferative potential. The current study examined mast cells obtained from adult skin and cul...
Mast cells in the kidney
Mast cells in the kidney
SUMMARY: Mast cells have become a recent concern in the nephrological world. The development of antibodies to mast cell‐specific enzymes, tryptase and chymase, has facilitated the ...
A Quantitative Analysis of Mast Cells in Inflammatory Periapical and Gingival Lesions
A Quantitative Analysis of Mast Cells in Inflammatory Periapical and Gingival Lesions
ABSTRACT
Aim
The aim of the study was to quantify the presence of mast cells in various inflammatory lesions like periapical granuloma, periapical cyst, inflammatory gingival hype...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
14th Annual Meeting, December 1980, Canberra1. Effect of dexamethasone on pineal β‐adrenoceptors. C. A. Maxwell, A. Foldes, N. T. Hinks and R. M. Hoskinson2. A clinicopathological ...
GW24-e1023 Advanced Glycation End Product Modified Low Density Lipoprotein Activates Mast Cells via Toll-Like 4 Receptor Pathway
GW24-e1023 Advanced Glycation End Product Modified Low Density Lipoprotein Activates Mast Cells via Toll-Like 4 Receptor Pathway
Objectives
To investigate the effects of AGE-LDL, in murine bone marrow-derived mast cells (mBMMCs), on mast cell degranulation and their possible signal pathways...

